Lack of efficacy of a nicotine transdermal treatment on motor and cognitive deficits in Parkinson's disease

Author： Lemay S. Chouinard S. Blanchet P. Masson H. Soland V. Beuter A. Bedard M.-A.

Publisher： Elsevier

ISSN： 0278-5846

Source： Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol.28, Iss.1, 2004-01, pp. : 31-39

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Cognitive Deficits and Psychosis in Parkinson's Disease: A Review of Pathophysiology and Therapeutic Options

By Williams-Gray Caroline H. Foltynie Thomas Lewis Simon J.G. Barker Roger A.

CNS Drugs, Vol. 20, Iss. 6, 2006-01 ,pp. : 477-505

Adis International

Access to resources Recommend Favorite

The effect of treatment on motor cortical activity in Parkinson's disease

By Rothwell J.C.

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 234-235

Elsevier

Access to resources Recommend Favorite

Rotigotine Transdermal Patch: A Review of its Use in the Treatment of Parkinson's Disease

By Sanford Mark Scott Lesley J.

CNS Drugs, Vol. 25, Iss. 8, 2011-08 ,pp. : 699-719

Adis International

Access to resources Recommend Favorite

Cabergoline: A Review of its Efficacy in the Treatment of Parkinson's Disease

By Wiseman L.R. Fitton A.

CNS Drugs, Vol. 12, Iss. 6, 1999-12 ,pp. : 485-497

Adis International

Access to resources Recommend Favorite

Chronic transdermal nicotine patch treatment effects on cognitive performance in age-associated memory impairment

By White Heidi Levin Edward

Psychopharmacology, Vol. 171, Iss. 4, 2004-02 ,pp. : 465-471

Springer Publishing Company

Access to resources Recommend Favorite